Understanding Vitreous Amyloidosis

Vitreous Amyloidosis: What to Know

Understanding Vitreous Amyloidosis

This section explains what vitreous amyloidosis is and how it affects the eye.

Amyloid fibrils accumulate in the clear, gel-like vitreous between the lens and retina. These deposits scatter light, creating a foggy or hazy view similar to looking through a steamed-up windshield.

Most cases of vitreous amyloidosis are linked to mutations in the TTR gene. The unstable proteins misfold, clump together, and can be one of the earliest signs of systemic disease.

Causes of Vitreous Amyloidosis

Causes of Vitreous Amyloidosis

Several underlying conditions can lead to amyloid deposits in the vitreous.

hATTR is the most common cause. Mutated transthyretin proteins form amyloid that can affect the eyes, heart, nerves, and kidneys.

Less frequently, AA or AL amyloidosis may involve the vitreous, though this is far rarer than hATTR-related disease.

In extremely rare situations, amyloid affects only the eye. Extensive testing is required to rule out systemic involvement.

Warning Signs and Symptoms

Warning Signs and Symptoms

Knowing early symptoms helps you seek timely evaluation.

Vision often declines gradually as deposits build, making reading or driving harder.

Patients notice drifting spots or strands that become denser over time.

The vitreous loses transparency, causing persistent haze even when other eye structures remain healthy.

Reduced contrast sensitivity in low light makes seeing at night challenging.

Bright light may cause discomfort or glare, especially during nighttime driving.

Some people report shadows or flickering shapes due to irregular light scattering.

Diagnosis Steps

Our specialists use multiple tools to confirm the condition and its extent.

These exams let us view characteristic vitreous opacities that suggest amyloid deposition.

When visibility is limited, ultrasound reveals highly reflective echoes consistent with amyloid.

Identifying TTR mutations confirms the hereditary nature and guides treatment and counseling.

Vitreous samples stained with Congo red show apple-green birefringence under polarized light, providing definitive proof.

Management and Treatment Options

Management and Treatment Options

Treatment plans focus on restoring clarity and preventing future vision loss.

Removing the cloudy vitreous allows light to reach the retina, reducing floaters and improving contrast.

Even after surgery, ongoing care is essential because amyloid production can continue.

  • New deposits may form and impair vision again.
  • Regular exams with imaging track any recurrence.
  • Secondary issues such as cataracts or pressure changes are monitored.

If symptoms are mild, careful observation is chosen until vision is significantly affected or risks change.

Collaboration with genetic counselors and other specialists ensures both eye health and overall wellness are addressed.

Systemic Associations and Genetic Counseling

Systemic Associations and Genetic Counseling

Vitreous amyloidosis often signals broader health concerns that need coordinated care.

Amyloid deposits in the eye can precede cardiac, neurologic, or renal involvement, so full medical work-ups detect issues early.

Counselors explain inheritance patterns, guide family screening, and support informed decisions about treatment and monitoring.

Partnering With Our Retina Specialists

Partnering With Our Retina Specialists

Managing vitreous amyloidosis requires expertise, regular monitoring, and compassionate support. Our team is committed to guiding you through diagnosis, treatment, and long-term care so you can enjoy clearer vision and better overall health.

Contact Us

Google review
4.5
(2196)

Monday: 8AM-4:30PM
Tuesday: 8AM-7PM
Wednesday: 8AM-4:30PM
Thursday: 8AM-7PM
Friday: 7:30AM-4:30PM
Saturday: 8AM-1:30PM
Sunday: Closed